Form 4: Zimmer Biomet Executive Reports Stock Transactions Following RSU Vesting

Zimmer Biomet Holdings, Inc.'s VP, Controller & CAO, Paul A. Stellato, reported the vesting of restricted stock units and subsequent stock transactions, including shares withheld for tax obligations.

Summary

• Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc. (ZBH), reported transactions on June 1, 2025, related to his beneficial ownership of company common stock.
• Mr. Stellato acquired 626 shares of common stock upon the vesting of restricted stock units (RSUs) at a price of $0.
• Concurrently, 197 shares of common stock were disposed of at a price of $92.24 per share to satisfy tax withholding obligations associated with the RSU vesting.
• Following these transactions, Mr. Stellato's direct beneficial ownership of Zimmer Biomet common stock stands at 2,772 shares.
• The restricted stock units vested in three equal tranches on June 1, 2023, June 1, 2024, and June 1, 2025.

Sentiment

Score: 7

Explanation: The filing indicates the routine vesting of executive compensation, which is a positive sign of executive retention and alignment with shareholder interests, with no negative implications for the company's operations or financial health. It is a standard, expected event.

Positives

• The vesting of restricted stock units (RSUs) for a key executive, Paul A. Stellato, indicates the successful fulfillment of long-term incentive compensation plans.
• The acquisition of common stock through RSU vesting aligns executive interests with shareholder value, promoting long-term commitment.

Negatives

• No specific negative events or financial performance issues are indicated in this Form 4 filing, as the reported transactions are routine executive compensation activities.

Risks

• This Form 4 filing primarily details executive stock transactions and does not contain information regarding company-specific operational risks or future challenges.

Future Outlook

This Form 4 filing details individual executive stock transactions and does not contain forward-looking statements or guidance regarding the company's future outlook or financial performance.

Management Comments

• This Form 4 filing does not contain direct quotes or paraphrased statements from company management regarding strategic direction or financial performance, as it is a statutory report of insider transactions.

Industry Context

This Form 4 filing details an individual executive's routine stock transactions related to compensation and does not provide information relevant to broader industry trends, competitive dynamics, or the overall market position of Zimmer Biomet Holdings, Inc.

Comparison to Industry Standards

• This Form 4 filing reports individual executive stock transactions and does not contain information suitable for comparison to global industry benchmarks, specific comparable companies, or project results. The vesting of RSUs and subsequent tax withholding are standard practices in executive compensation across various industries.

Management Changes

Corporate Governance

Legal Proceedings

• This Form 4 filing does not disclose any litigation or regulatory matters involving Zimmer Biomet Holdings, Inc. or its executives.

Related Party Transactions

• This Form 4 filing details the withholding of shares by the company to cover tax obligations related to executive compensation, which is a standard practice and not indicative of unusual related party dealings.

Stakeholder Impact

• The reported transactions are routine executive compensation events and are unlikely to have a significant direct impact on shareholders beyond the standard alignment of executive and shareholder interests. No direct impact on employees, customers, suppliers, or creditors is indicated.

Next Steps

• This Form 4 filing does not specify future company actions, events, or milestones beyond the reported executive stock transactions.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership, Paul A. Stellato